ABAT | 4-aminobutyrate aminotransferase | Disease related genes Enzymes FDA approved drug targets Mitochondrial proteins Plasma proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/41528/91017_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
ABL1 | C-abl oncogene 1, non-receptor tyrosine kinase | Cancer-related genes Disease related genes Enzymes FDA approved drug targets RAS pathway related proteins
| | | ![](/images/27280/ihc_cell_selected_60x60.jpg) | ![](/images/28409/61493_B_9_3_rna_selected_60x60.jpg) | Expressed in all |
ACE | Angiotensin I converting enzyme | Candidate cardiovascular disease genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images/2426/ihc_cell_selected_60x60.jpg) | ![](/images/2426/6196_B_7_3_rna_selected_60x60.jpg) | Group enriched |
ACE2 | Angiotensin I converting enzyme 2 | Enzymes FDA approved drug targets Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/26174/58083_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
ACHE | Acetylcholinesterase (Yt blood group) | Blood group antigen proteins Enzymes FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | ![](/images/19704/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/19704/44576_B_8_6_rna_selected_60x60.jpg) | Tissue enriched |
ADA | Adenosine deaminase | Disease related genes Enzymes FDA approved drug targets Plasma proteins
| | | ![](/images/4307/ihc_cell_selected_60x60.jpg) | ![](/images/23884/54930_B_9_3_rna_selected_60x60.jpg) | Tissue enriched |
ADH1A | Alcohol dehydrogenase 1A (class I), alpha polypeptide | Enzymes FDA approved drug targets Plasma proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/60902/141575_B_8_3_rna_selected_60x60.jpg) | Tissue enriched |
ADH1B | Alcohol dehydrogenase 1B (class I), beta polypeptide | Enzymes FDA approved drug targets Plasma proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/60902/141575_B_8_3_rna_selected_60x60.jpg) | Group enriched |
ADK | Adenosine kinase | Disease related genes Enzymes FDA approved drug targets
| ![](/images/38409/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/38391/80914_A_3_7_rna_selected_60x60.jpg) | Expressed in all |
AKR1C2 | Aldo-keto reductase family 1, member C2 | Disease related genes Enzymes FDA approved drug targets
| | ![](/images_static/na_center.gif) | | ![](/images/47304/103865_B_9_2_rna_selected_60x60.jpg) | Tissue enhanced |
AKR1D1 | Aldo-keto reductase family 1, member D1 | Disease related genes Enzymes FDA approved drug targets
| | ![](/images_static/na_center.gif) | ![](/images/57002/ihc_cell_selected_60x60.jpg) | ![](/images/57002/131566_B_7_3_rna_selected_60x60.jpg) | Tissue enriched |
ALAD | Aminolevulinate dehydratase | Disease related genes Enzymes FDA approved drug targets Plasma proteins
| | ![](/images_static/na_center.gif) | | ![](/images/21023/51724_B_9_2_rna_selected_60x60.jpg) | Expressed in all |
ALOX5 | Arachidonate 5-lipoxygenase | Enzymes FDA approved drug targets
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/5066/13292_B_7_8_rna_selected_60x60.jpg) | Tissue enhanced |
AMY2A | Amylase, alpha 2A (pancreatic) | Enzymes FDA approved drug targets Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images/45960/ihc_cell_selected_60x60.jpg) | ![](/images/45394/119576_B_4_1_rna_selected_60x60.jpg) | Tissue enriched |
AOC3 | Amine oxidase, copper containing 3 | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/25797/57832_B_9_2_rna_selected_60x60.jpg) | Tissue enhanced |
APEX1 | APEX nuclease (multifunctional DNA repair enzyme) 1 | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins
| | | | ![](/images/2564/7318_B_9_3_rna_selected_60x60.jpg) | Expressed in all |
ATIC | 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/13462/28449_B_2_4_rna_selected_60x60.jpg) | Expressed in all |
ATP1A1 | ATPase, Na+/K+ transporting, alpha 1 polypeptide | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/18702/42623_B_8_6_rna_selected_60x60.jpg) | Expressed in all |
ATP2C1 | ATPase, Ca++ transporting, type 2C, member 1 | Disease related genes Enzymes FDA approved drug targets Predicted membrane proteins Transporters
| | ![](/images/10207/if_selected_60x60.jpg) | ![](/images/10207/ihc_cell_selected_60x60.jpg) | ![](/images/35116/84725_B_9_5_rna_selected_60x60.jpg) | Expressed in all |
BCR | Breakpoint cluster region | Cancer-related genes Disease related genes Enzymes FDA approved drug targets
| | ![](/images/38337/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/38337/81434_B_8_7_rna_selected_60x60.jpg) | Expressed in all |
BLVRB | Biliverdin reductase B (flavin reductase (NADPH)) | Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | ![](/images/41937/90336_B_1_6_rna_selected_60x60.jpg) | Expressed in all |
BRAF | V-raf murine sarcoma viral oncogene homolog B | Cancer-related genes Disease related genes Enzymes FDA approved drug targets
| | ![](/images_static/na_center.gif) | | ![](/images/1328/3905_B_2_3_rna_selected_60x60.jpg) | Expressed in all |
CA1 | Carbonic anhydrase I | Enzymes FDA approved drug targets Plasma proteins
| | ![](/images_static/na_center.gif) | | ![](/images/6558/22094_B_9_1_rna_selected_60x60.jpg) | Group enriched |
CA14 | Carbonic anhydrase XIV | Enzymes FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| ![](/images/8482/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | | ![](/images/8482/23361_B_8_6_rna_selected_60x60.jpg) | Tissue enhanced |
CA2 | Carbonic anhydrase II | Disease related genes Enzymes FDA approved drug targets Plasma proteins
| | ![](/images_static/na_center.gif) | ![](/images/1550/ihc_cell_selected_60x60.jpg) | ![](/images/10102/25628_B_3_8_rna_selected_60x60.jpg) | Tissue enhanced |
CA3 | Carbonic anhydrase III, muscle specific | Enzymes FDA approved drug targets Plasma proteins
| | ![](/images_static/na_center.gif) | | ![](/images/21775/48848_B_7_7_rna_selected_60x60.jpg) | Tissue enriched |
CA4 | Carbonic anhydrase IV | Disease related genes Enzymes FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | ![](/images/17258/ihc_cell_selected_60x60.jpg) | ![](/images/11089/39733_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
CAT | Catalase | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins
| | | ![](/images/1515/ihc_cell_selected_60x60.jpg) | ![](/images/55838/135651_B_8_2_rna_selected_60x60.jpg) | Expressed in all |
CES1 | Carboxylesterase 1 | Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/12023/30143_B_7_4_rna_selected_60x60.jpg) | Group enriched |
CFTR | Cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/21939/147487_B_6_5_rna_selected_60x60.jpg) | Group enriched |
CHD1 | Chromodomain helicase DNA binding protein 1 | Enzymes FDA approved drug targets
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/22236/109217_B_7_7_rna_selected_60x60.jpg) | Expressed in all |
CKB | Creatine kinase, brain | Cancer-related genes Candidate cardiovascular disease genes Enzymes FDA approved drug targets Plasma proteins
| | ![](/images_static/na_center.gif) | | ![](/images/47313/104793_A_1_6_rna_selected_60x60.jpg) | Expressed in all |
CKM | Creatine kinase, muscle | Candidate cardiovascular disease genes Enzymes FDA approved drug targets Plasma proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/47859/107889_B_8_2_rna_selected_60x60.jpg) | Tissue enriched |
CKMT2 | Creatine kinase, mitochondrial 2 (sarcomeric) | Enzymes FDA approved drug targets Mitochondrial proteins Plasma proteins
| | ![](/images_static/na_center.gif) | ![](/images/51880/ihc_cell_selected_60x60.jpg) | ![](/images/51880/120103_B_7_6_rna_selected_60x60.jpg) | Group enriched |
COMT | Catechol-O-methyltransferase | Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins
| | ![](/images/1169/if_selected_60x60.jpg) | | ![](/images/11233/26802_A_3_6_rna_selected_60x60.jpg) | Expressed in all |
CPS1 | Carbamoyl-phosphate synthase 1, mitochondrial | Disease related genes Enzymes FDA approved drug targets Mitochondrial proteins Plasma proteins
| | ![](/images/21400/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/3781/10124_B_8_6_rna_selected_60x60.jpg) | Group enriched |
CPT1A | Carnitine palmitoyltransferase 1A (liver) | Disease related genes Enzymes FDA approved drug targets Mitochondrial proteins Plasma proteins Predicted membrane proteins
| | | | ![](/images/8835/24151_B_8_1_rna_selected_60x60.jpg) | Expressed in all |
CPT2 | Carnitine palmitoyltransferase 2 | Disease related genes Enzymes FDA approved drug targets Mitochondrial proteins Plasma proteins
| | | | ![](/images/28201/59343_B_9_2_rna_selected_60x60.jpg) | Expressed in all |
CYP11B1 | Cytochrome P450, family 11, subfamily B, polypeptide 1 | Disease related genes Enzymes FDA approved drug targets Mitochondrial proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/49171/142129_B_8_2_rna_selected_60x60.jpg) | Tissue enriched |
CYP17A1 | Cytochrome P450, family 17, subfamily A, polypeptide 1 | Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/48533/142448_B_7_3_rna_selected_60x60.jpg) | Tissue enriched |
CYP19A1 | Cytochrome P450, family 19, subfamily A, polypeptide 1 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images/51194/ihc_cell_selected_60x60.jpg) | ![](/images/355/2188_B_7_4_rna_selected_60x60.jpg) | Tissue enriched |
CYP51A1 | Cytochrome P450, family 51, subfamily A, polypeptide 1 | Enzymes FDA approved drug targets Predicted membrane proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/41325/88210_B_9_2_rna_selected_60x60.jpg) | Expressed in all |
DBH | Dopamine beta-hydroxylase (dopamine beta-monooxygenase) | Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| ![](/images/5960/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | | ![](/images/5960/15920_B_9_1_rna_selected_60x60.jpg) | Tissue enriched |
DCK | Deoxycytidine kinase | Enzymes FDA approved drug targets
| | ![](/images/59609/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/62773/141174_A_1_8_rna_selected_60x60.jpg) | Expressed in all |
DDC | Dopa decarboxylase (aromatic L-amino acid decarboxylase) | Disease related genes Enzymes FDA approved drug targets
| | ![](/images/17742/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/17742/39381_B_7_7_rna_selected_60x60.jpg) | Tissue enhanced |
DHODH | Dihydroorotate dehydrogenase (quinone) | Disease related genes Enzymes FDA approved drug targets Mitochondrial proteins Predicted membrane proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/10123/37043_B_8_5_rna_selected_60x60.jpg) | Expressed in all |
DNMT1 | DNA (cytosine-5-)-methyltransferase 1 | Disease related genes Enzymes FDA approved drug targets Plasma proteins Transcription factors
| | | | ![](/images/5876/14024_A_7_1_rna_selected_60x60.jpg) | Expressed in all |
DPEP1 | Dipeptidase 1 (renal) | Enzymes FDA approved drug targets Predicted secreted proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/9426/25394_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
DPP4 | Dipeptidyl-peptidase 4 | CD markers Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/45970/113237_B_8_3_rna_selected_60x60.jpg) | Tissue enhanced |
EGFR | Epidermal growth factor receptor | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | ![](/images/18530/41188_B_6_4_rna_selected_60x60.jpg) | Tissue enhanced |